Ameritas Advisory Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Ameritas Advisory Services's JAZZ Position: Q2 2026 in Review
Ameritas Advisory Services opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 193 shares worth $46.5K. The stake represents ﹤0.01% of the portfolio and ranks #1260 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in JAZZ as recently as Q2 2025.
Ameritas Advisory Services first reported a position in JAZZ in Q1 2023 and has held it in 3 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Ameritas Advisory Services held 193 shares of Jazz Pharmaceuticals worth $46.5K as of Q2 2026.
- Jazz Pharmaceuticals was a new Ameritas Advisory Services position in Q2 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1260 holding.
- Ameritas Advisory Services first reported a position in Jazz Pharmaceuticals in Q1 2023 and has held it in 3 quarters since.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.